Goldman: Hedge Funds Bet on US Healthcare Stocks at 5-Year High

Although GOOGL shares experienced a 5% decline in the last trading session, the RSI remains neutral at 49, and the MACD continues to stay above the signal line. While news headlines have focused on the healthcare sector, there is no direct impact on technology stocks. In the short term, the price is expected to find support at the 20-day moving average of $325.53. However, remaining below the 50-day moving average of $341.64 may limit upward movement. Therefore, it would be prudent to wait for further catalysts before determining a clear direction.

UNH shares have fallen 4.1% in the last 24 hours, dropping to 418.48. While the RSI at 37.7 approaches oversold territory, the MACD remains below the signal line in negative territory. Trading below the 20- and 50-day moving averages indicates short-term weakness. Although news headlines highlight hedge funds' strong interest in the healthcare sector, this may be insufficient to offset the current selling pressure. Given the deterioration in technical indicators and the price testing critical support levels, downside risks may persist in the near term.

JNJ stock has risen 6.7% in the last 24 hours, with its RSI entering overbought territory at 82. While the news indicates increased hedge fund interest in the healthcare sector, technical indicators suggest a potential short-term correction or consolidation. Although the MACD remains positive, overbought levels imply limited upside momentum. Therefore, a neutral stance may be warranted due to short-term directional uncertainty.

Hedge funds' interest in US healthcare stocks has reached a five-year high, indicating increased institutional demand for major pharmaceutical companies such as PFE. Technically, while the RSI is neutral at 50, the price trading just below the SMA20 and SMA50 offers short-term recovery potential. Although the MACD line being below the signal line suggests weak momentum, the positive news flow could act as a catalyst. Despite a slight decline in the last 24 hours, rising institutional interest may support the stock upward. However, the lack of a clear buy signal from technical indicators limits the upside expectation to cautious optimism.